CN Patent

CN102112483A — (2s,3r,4r,5s,6r)-2-(4-氯-3-(4-乙氧基苄基)苯基)-6-(甲基硫)四氢-2h-吡喃-3,4,5-三醇的固体形式及其使用方法

Assigned to Lexicon Pharmaceuticals Inc · Expires 2011-06-29 · 15y expired

What this patent protects

本发明公开了无水(2S，3R，4R，5S，6R)-2-(4-氯-3-(4-乙氧基苄基)苯基)-6-(甲基硫)四氢-2H-吡喃-3，4，5-三醇的固体形式，以及它们在治疗多种疾病和病症中的使用方法。

USPTO Abstract

本发明公开了无水(2S，3R，4R，5S，6R)-2-(4-氯-3-(4-乙氧基苄基)苯基)-6-(甲基硫)四氢-2H-吡喃-3，4，5-三醇的固体形式，以及它们在治疗多种疾病和病症中的使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102112483A
Jurisdiction
CN
Classification
—
Expires
2011-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Lexicon Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.